drug

AVB-101

Phase 2updated 3mo ago

by AviadoBio Ltd

Phase 2

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying AVB-101

phase2A Study to Evaluate the Safety and Effect of AVB-101, a Gene Therapy Product, in Subjects With a Genetic Sub-type of Frontotemporal Dementia (FTD-GRN)recruitingn=18

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 32m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

AVB-101

Phase 2updated 3mo ago

by AviadoBio Ltd

Phase 2

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying AVB-101

phase2A Study to Evaluate the Safety and Effect of AVB-101, a Gene Therapy Product, in Subjects With a Genetic Sub-type of Frontotemporal Dementia (FTD-GRN)recruitingn=18

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 32m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

AVB-101

all catalysts(0)

Trials studying AVB-101

News(0)

Report a data issue

comments(0)

AVB-101

all catalysts(0)

Trials studying AVB-101

News(0)

Report a data issue

comments(0)